Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma
β Scribed by Ilaria Lenci; Laura Tariciotti; Leonardo Baiocchi; Tommaso Maria Manzia; Luca Toti; Paolo Craboledda; Francesco Callea; Mario Angelico; Giuseppe Tisone
- Book ID
- 110917028
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 178 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. The role of orthotopic liver transplantation in the treatment of patients with cirrhosis and hepatocellular carcinoma is controversial, and determining which patients are likely to have a good outcome after liver transplantation is difficult. Methods. We studied 48 patients with cirrhos
Improved outcome after liver transplantation (LTX) for hepatocellular carcinoma (HCC) made LTX a legitimate treatment of the disease. We analyzed trends of LTX for HCC with tumors known before transplantation in 902 patients in a large international registry across 3 periods: 1983-1990, 1991-1996, a